Cinclus Pharma Holding AB (CINPHA.ST)
These figures are from 2025-01-01.
Nothing newer has been filed in the 21 months since.
Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
filled in.
Amounts in SEK.
The same series drawn ›
As last reported
The newest period the filing supports for each figure, in SEK.
| Figure | Period | Amount | Year on year |
|---|
| Operating Income |
2024 · ending 31 December 2024 |
-169.6M |
— |
| Net Income |
2024 · ending 31 December 2024 |
-168M |
— |
| Operating Cash Flow |
2024 · ending 31 December 2024 |
-178.4M |
— |
| EPS |
2024 · ending 31 December 2024 |
-4.54 |
— |
Every period
Operating Income Annual
| Period | Ending | Operating Income |
|---|
| 2024 | 2024-12-31 | -169.6M |
|---|
| 2023 | 2023-12-31 | -201M |
|---|
Net Income Annual
| Period | Ending | Net Income |
|---|
| 2024 | 2024-12-31 | -168M |
|---|
| 2023 | 2023-12-31 | -215.1M |
|---|
Operating Cash Flow Annual
| Period | Ending | Operating Cash Flow |
|---|
| 2024 | 2024-12-31 | -178.4M |
|---|
| 2023 | 2023-12-31 | -209.2M |
|---|
EPS Annual
The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.
| Period | Ending | EPS |
|---|
| 2024 | 2024-12-31 | -4.54 |
|---|
| 2023 | 2023-12-31 | -8.20 |
|---|